NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding NeuroPace Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 17.4M | 17.7M | +313.0K (+1.8%) |
| Value | $25.9M | $82.0M | +$56.1M (+217.0%) |
New holders (3)
Institutions that held NeuroPace Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kent Lake Capital LLC | 127,676 | $592.4K | 0.40% |
| SG Americas Securities, LLC | 25,388 | $118.0K | 0.00% |
| Susquehanna International Group, LLP | 14,052 | $65.2K | 0.00% |
Sold out (3)
Institutions that held NeuroPace Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| American Century Companies Inc | 72,508 | $108.0K |
| Jacobs Levy Equity Management, Inc | 23,692 | $35.3K |
| Royal Bank of Canada | 58 | $0 |